419 related articles for article (PubMed ID: 22895463)
1. Viral hepatitis and HIV infection among injection drug users in a central Iranian City.
Sofian M; Aghakhani A; Banifazl M; Azadmanesh K; Farazi AA; McFarland W; Eslamifar A; Ramezani A
J Addict Med; 2012 Dec; 6(4):292-6. PubMed ID: 22895463
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
4. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Barrio E
Am J Gastroenterol; 2000 May; 95(5):1316-22. PubMed ID: 10811346
[TBL] [Abstract][Full Text] [Related]
7. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
[TBL] [Abstract][Full Text] [Related]
8. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
9. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
[TBL] [Abstract][Full Text] [Related]
10. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
12. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
13. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
14. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
Aghakhani A; Banifazl M; Kalantar E; Eslamifar A; Ahmadi F; Razeghi E; Atabak S; Amini M; Khadem-Sadegh A; Ramezani A
Ther Apher Dial; 2010 Jun; 14(3):349-53. PubMed ID: 20609190
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
[TBL] [Abstract][Full Text] [Related]
16. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
Gibney KB; Torresi J; Lemoh C; Biggs BA
J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
[TBL] [Abstract][Full Text] [Related]
18. The risk of HIV and HCV infections among injection drug users in northeast India.
Mahanta J; Borkakoty B; Das HK; Chelleng PK
AIDS Care; 2009 Nov; 21(11):1420-4. PubMed ID: 20024719
[TBL] [Abstract][Full Text] [Related]
19. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
